Share Name Share Symbol Market Type Share ISIN Share Description
Halma Plc LSE:HLMA London Ordinary Share GB0004052071 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  67.00 3.22% 2,147.00 2,155.00 2,157.00 2,177.00 2,094.00 2,124.00 2,138,132 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 1,318.2 252.9 53.6 40.0 8,141

Halma PLC Acquisition

19/11/2021 7:00am

UK Regulatory (RNS & others)

Halma (LSE:HLMA)
Historical Stock Chart

From May 2021 to May 2022

Click Here for more Halma Charts.


RNS Number : 8859S

Halma PLC

19 November 2021

Halma plc

('Halma' or the 'Group')


Halma, the global group of life-saving technology companies focused on growing a safer, cleaner and healthier future for everyone every day, today announces that it has acquired Infinite Leap, Inc. (Infinite Leap) for its Medical sector business, CenTrak, which provides real-time location services for healthcare facilities.

Infinite Leap is a healthcare consulting and services provider for real-time location technologies, based in Fargo, North Dakota, USA, which is also developing unique new hardware and software solutions for applications adjacent to CenTrak's core market. The initial cash consideration is US$30m (approximately GBP22m), on a cash and debt free basis, which will be funded from Halma's existing facilities. Additional earn-out considerations are payable in cash, based on growth targets in each of the two financial years to 30 September 2023, up to an aggregate maximum of US$17m (approximately GBP13m). Infinite Leap's unaudited revenue for the 12 months to 31 March 2021 was US$6.8m (approximately GBP5m) (see "Further information on Infinite Leap" below for further details).

Andrew Williams, Group Chief Executive of Halma, commented:

"Infinite Leap is an exciting acquisition that will enhance CenTrak's capabilities as an end-to-end enterprise solutions provider for healthcare organisations. It will enable CenTrak to broaden its services, solutions and technologies to support the growing needs of healthcare providers, particularly larger organisations with networks of healthcare facilities, in the post-pandemic world."

For further information, please contact:

Halma plc

Andrew Williams, Group Chief Executive +44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer

Charles King, Head of Investor Relations +44 (0) 7776 685948

Clayton Hirst, Director of Corporate Affairs +44 (0) 7384 796 013

MHP Communications

Andrew Jaques / Rachel Farrington +44 (0)20 3128 8572

A copy of this announcement, together with other information about Halma, is available at

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.

Its purpose defines the three broad market areas where it operates:

   --    Safety: protecting life as populations grow and protecting worker safety. 
   --    Environment: improving food and water quality, and monitoring air pollution. 
   --    Health: meeting rising healthcare demand as growing populations age and lifestyles change. 

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

In January 2021, Halma was named Britain's Most Admired Company by Management Today.

Further information on Infinite Leap

Infinite Leap, based in Fargo, North Dakota, USA, is a healthcare consulting and services provider for real-time location technologies. The company delivers industry leading patient and staff workflow software as well as end-to-end services - from solution design and business planning to deployment, training, 24/7 support, and managed services. Infinite Leap has helped healthcare providers successfully implement hundreds of projects and dozens of unique use cases, including patient flow optimisation, asset management, environmental monitoring, staff safety, wayfinding, and more.

Infinite Leap's unaudited revenue for the 12 months to 31 March 2021 of US$6.8m (approximately GBP5m) was principally derived from its Enterprise Solutions business, whose growth rate and return on sales are above Halma's target ranges. The business also includes a start-up, Prompt Health, which is developing a lower-cost hardware and software solution for use the ambulatory (out-patient) sector. Prompt Health is currently loss-making and is expected to become profitable over the next 2 to 3 years.

More information on Infinite Leap is available at


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

November 19, 2021 02:00 ET (07:00 GMT)

1 Year Halma Chart

1 Year Halma Chart

1 Month Halma Chart

1 Month Halma Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220521 09:46:32